Influences of the Global Deterioration Scale according to Routine Blood Chemistry Results
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Neurocognitive testing commonly uses the MMSE (Mini-Mental State Examination) to evaluate the overall cognitive function of patients at outpatient clinics, but the MMSE has recently been extensively used in the SNSB II (Seoul Neuropsychological Screening Battery II) for making diagnoses. We retrospectively investigated the results of routine neurocognitive tests and the results of the blood tests of 120 elderly patients who had been referred to a South Central Medical Center from 2017 to 2018 and who had been examined at a public health center. These subjects’ space-time capability was high on the sub-region of the global deterioration scale (GDS). GDS showed a significant increase as the Na decreased on the electrolyte analysis. The subjects’ concentration, their language-based orientation for space and time, their memory, and their scores for the frontal lobe function on GDS showed statistically significant reductions (P＜0.001) For the normal and abnormal groups according to the ALT and creatinine levels, the frontal/execute function areas showed statistically significant differences (P＜0.001) as well as negative correlation between GDS and ALT (P＜0.01). In conclusion, this study provides basic information to develop test items that are important for patient screening and diagnosis, and several routine blood chemistry factors provide basic information for diagnosing and assessing the status and progress of cognitively impaired patients.
Abstract
Neurocognitive testing commonly uses the MMSE (Mini-Mental State Examination) to evaluate the overall cognitive function of patients at outpatient clinics, but the MMSE has recently been extensively used in the SNSB II (Seoul Neuropsychological Screening Battery II) for making diagnoses. We retrospectively investigated the results of routine neurocognitive tests and the results of the blood tests of 120 elderly patients who had been referred to a South Central Medical Center from 2017 to 2018 and who had been examined at a public health center. These subjects’ space-time capability was high on the sub-region of the global deterioration scale (GDS). GDS showed a significant increase as the Na decreased on the electrolyte analysis. The subjects’ concentration, their language-based orientation for space and time, their memory, and their scores for the frontal lobe function on GDS showed statistically significant reductions (P＜0.001) For the normal and abnormal groups according to the ALT and creatinine levels, the frontal/execute function areas showed statistically significant differences (P＜0.001) as well as negative correlation between GDS and ALT (P＜0.01). In conclusion, this study provides basic information to develop test items that are important for patient screening and diagnosis, and several routine blood chemistry factors provide basic information for diagnosing and assessing the status and progress of cognitively impaired patients.
참고문헌 (25)
- Kim JM, "Validity of Korean form of Geriatric depression scale(KGDS)among cognitively impaired Korean elderly and development of a 15-item short version(KGDS-15)", Int J Met Psychiatr Res, 10, pp.204~210 (2001)[DOI]
- 김재민, "치매 선별을 위한 MMSE-K와 K-MMSE의 진단 타당도 비교", 신경정신의학, 42(1), pp.124~130 (2003), 대한신경정신의학회
- Kang Y, "A validity study on the Korean mini-mental state examination(K-MMSE)in dementia patients", J Korean Neuropsychiatr Assoc, 15, pp.300~308 (1997)
- 오은아, "치매선별검사로서 K-MMSE의 타당도 연구: 종합적인 신경심리학적 평가와의 비교", Dementia and Neurocognitive Disorders(대한치매학회지), 9(1), pp.8~12 (2010), 대한치매학회
- Hoops S, "Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease", Neurology, 73, pp.1738~1745 (2009)
- Svensson T, "The association between midlife serum high-density lipoprotein and mild cognitive impairment and dementia after 19 years of follow-up", Transl Psychiatry, 9, pp.26~ (2019)[DOI]
- Mills JH, "Ballenger’s manual of otorhinolaryngology head and neck surgery", pp.333~343 (2009), People’s medical publishing house
- Livingston G, "Dementia prevention, intervention, and care", Lancet, 390, pp.2673~2734 (2017)[DOI]
- Ozawa M, "Self-reported dietary intake of potassium, calcium, and magnesium and risk of dementia in the Japanese: the Hisayama Study", J Am Geriatr Soc, 60, pp.1515~1520 (2012)
- Sims Wright R, "Fasting glucose and glucose tolerance as potential predictors of neurocognitive function among nondiabetic older adults", J Clin Exp Neuropsychol, 37, pp.49~60 (2015)[DOI]
- Anfinson TJ, "Screening laboratory evaluation in psychiatric patients : a review", Gen Hosp Psychiatry, 14, pp.248~257 (1992)
- Sheline Y, "Cost and utility of routine admission laboratory testing for psychiatric inpatients", Gen Hosp Psychiatry, 12, pp.329~334 (1990)
- Reisberg B, "The global deterioration scale (GDS) for assessment of primary degenerative dementia", American Journal of Psychiatry, 139(9), pp.1136~1139 (1982), American Psychiatric Association Publishing[DOI]
- B. T. Hyman, "New Neuropathological Criteria for Alzheimer Disease", Archives of Neurology, 55(9), pp.1174~1176 (1998), American Medical Association (AMA)[DOI]
- Tsigelny IF, "Mechanisms of hybrid oligomer formation in the pathogenesis of combined Alzheimer’s and Parkinson’s diseases", PLoS One, 3, pp.e3135~ (2008)[DOI]
- Gallardo G, "A molecular pathway of neurodegeneration linking alpha-synuclein to Apo E and A beta peptides", Nat Neurosci, 11, pp.301~308 (2008)
- Choi SH, "Estimating the validity of the Korean version of expanded Clinical Dementia Rating(CDR)Scale", J Korean Neurol Assoc, 19, pp.585~591 (2001)
- Sloane Heller, "Validation of the English Version of the Multimodal Assessment of Capacities in Severe Dementia (MAC-SD): A Cognitive and Functional Scale for Use in Severe Dementia", Journal of Alzheimer's Disease Reports, 1(1), pp.249~262 (2017), IOS Press[DOI]
- Henrik Zetterberg, "Blood-based molecular biomarkers for Alzheimer’s disease", Molecular Brain, 12(1) (2019), Springer Science and Business Media LLC[DOI]
- Brenda C.T. Kieboom, "Serum magnesium is associated with the risk of dementia", Neurology, 89(16), pp.1716~1722 (2017), Ovid Technologies (Wolters Kluwer Health)[DOI]
- Shen Y, "Cognitive decline, dementia, Alzheimer's disease and presbycusis : examination of the possible molecular mechanism", Front Neurosci, 12, pp.394~ (2018)[DOI]
- Khan AA, "Serum uric acid level and association with cognitive impairment and dementia : systematic review and meta-analysis", Age(Dordr), 38, pp.16~ (2016)[DOI]
- May A Beydoun, "Epidemiologic studies of modifiable factors associated with cognition and dementia: systematic review and meta-analysis", BMC Public Health, 14(1), pp.643~ (2014), Springer Science and Business Media LLC[DOI]
- Vintimilla RM, "The link between potassium and mild cognitive impairment in Mexican-Americans", Dement Geriatr Cogn Dis Extra, 8, pp.151~157 (2018)[DOI]
- Wang HX, "Association of lifelong exposure to cognitive reserve-enhancing factors with dementia risk : a community-based cohort study", PLoS Med, 14, pp.E1002251~ (2017)